Mechanisms and Predictors of Carotid Artery Stent Restenosis
A Serial Intravascular Ultrasound Study
David J. Clark, MD*, ,
Sara Lessio, MD*,
Margaret O'Donoghue, MD*,
Con Tsalamandris, MD ,
Robert Schainfeld, DO* and
Kenneth Rosenfield, MD, FACC*,*
* Division of Cardiovascular Medicine and Research, St. Elizabeth's Medical Center of Boston, Boston, Massachusetts
Departments of Cardiology and Medicine, Austin Hospital, Melbourne, Australia

View larger version (86K):
[in a new window]
|
Figure 1 Designated sites of quantitative carotid angiography (QCA) and intravascular ultrasound (IVUS) measurements. QCA: (A) before intervention; (B) post-carotid stent deployment; (C) six-month follow-up. (D) IVUS: (Top) calcified plaque at lesion site pre-intervention; (Bottom) internal carotid artery (ICA) stent post-procedure. 1 = distal ICA reference; 2 = lesion site; 3 = proximal common carotid artery (CCA) reference; 4 = lesion site in-stent; 5 = ICA stent minimal luminal diameter (MLD); 6 = ICA stent reference site; 7 = CCA stent MLD; 8 = CCA stent reference site; 9 = lumen MLD (line) and lumen area (circle); 10 = stent MLD (line) and stent area (circle).
|
|

View larger version (16K):
[in a new window]
|
Figure 3 Correlation between amount of neointimal hyperplasia (NIH, mm2) and late stent enlargement ( stent, mm2) at the internal carotid artery lesion site (r = 0.64; p < 0.001).
|
|

View larger version (12K):
[in a new window]
|
Figure 4 (Left) Correlation between the immediate post-procedure distal internal carotid artery (ICA) reference vessel diameter (mm) measured by quantitative carotid angiography (QCA) and percentage restenotic area after six months. (Right) Correlation between the immediate post-procedure ICA stent minimal lumen diameter (MLD) (mm) measured by QCA and percentage restenotic area after six months.
|
|
|